CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues

被引：0
|
作者：
Giao Q. Phan
Jeffrey S. Weber
Vernon K. Sondak
机构：
[1] H. Lee Moffitt Cancer Center,Division of Cutaneous Oncology
[2] H. Lee Moffitt Cancer Center,The Donald A. Adam Comprehensive Melanoma Research Center
[3] University of South Florida College of Medicine,Department of Oncologic Sciences
[4] University of South Florida College of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2008年 / 15卷
关键词：
Immune-related Adverse Events (IRAEs); Ipilimumab; Tremelimumab; Hypophysitis; Infliximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3014 / 3021
页数：7
相关论文
共 50 条
  • [1] CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues
    Phan, Giao Q.
    Weber, Jeffrey S.
    Sondak, Vernon K.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) : 3014 - 3021
  • [2] CTLA-4 blockade and the renaissance of cancer immunotherapy
    Mocellin, Simone
    Nitti, Donato
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 187 - 196
  • [3] Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
    Van Allen, Eliezer M.
    Miao, Diana
    Schilling, Bastian
    Shukla, Sachet A.
    Blank, Christian
    Zimmer, Lisa
    Sucker, Antje
    Hillen, Uwe
    Foppen, Marnix H. Geukes
    Goldinger, Simone M.
    Utikal, Jochen
    Hassel, Jessica C.
    Weide, Benjamin
    Kaehler, Katharina C.
    Loquai, Carmen
    Mohr, Peter
    Gutzmer, Ralf
    Dummer, Reinhard
    Gabriel, Stacey
    Wu, Catherine J.
    Schadendorf, Dirk
    Garraway, Levi A.
    SCIENCE, 2015, 350 (6257) : 207 - 211
  • [4] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Xuexiang Du
    Fei Tang
    Mingyue Liu
    Juanjuan Su
    Yan Zhang
    Wei Wu
    Martin Devenport
    Christopher A Lazarski
    Peng Zhang
    Xu Wang
    Peiying Ye
    Changyu Wang
    Eugene Hwang
    Tinghui Zhu
    Ting Xu
    Pan Zheng
    Yang Liu
    Cell Research, 2018, 28 : 416 - 432
  • [5] CTLA-4 blockade: therapeutic potential in cancer treatments
    Tarhini, Ahmad A.
    Iqbal, Fatima
    ONCOTARGETS AND THERAPY, 2010, 3 : 15 - 25
  • [6] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Du, Xuexiang
    Tang, Fei
    Liu, Mingyue
    Su, Juanjuan
    Zhang, Yan
    Wu, Wei
    Devenport, Martin
    Lazarski, Christopher A.
    Zhang, Peng
    Wang, Xu
    Ye, Peiying
    Wang, Changyu
    Hwang, Eugene
    Zhu, Tinghui
    Xu, Ting
    Zheng, Pan
    Liu, Yang
    CELL RESEARCH, 2018, 28 (04) : 416 - 432
  • [7] CTLA-4 blockade: Autoimmunity as treatment
    Kapadia, D
    Fong, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 8926 - 8928
  • [8] Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
    Wilkins, Anna
    McDonald, Fiona
    Harrington, Kevin
    Melcher, Alan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Intralesional administration of CTLA-4 blocking monoclonal antibodies as a means to optimize bladder cancer therapy
    van Hooren, Luuk
    Sandin, Linda
    Moskalev, Igor
    Ellmark, Peter
    Dimberg, Anna
    Black, Peter
    Totterman, Thomas H.
    Mangsbo, Sara M.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [10] Radiotherapy induces responses of lung cancer to CTLA-4 blockade
    Formenti, Silvia C.
    Rudqvist, Nils-Petter
    Golden, Encouse
    Cooper, Benjamin
    Wennerberg, Erik
    Lhuillier, Claire
    Vanpouille-Box, Claire
    Friedman, Kent
    de Andrade, Lucas Ferrari
    Wucherpfennig, Kai W.
    Heguy, Adriana
    Imai, Naoko
    Gnjatic, Sacha
    Emerson, Ryan O.
    Zhou, Xi Kathy
    Zhang, Tuo
    Chachoua, Abraham
    Demaria, Sandra
    NATURE MEDICINE, 2018, 24 (12) : 1845 - +
12345